Diatos Licenses European Rights To Cancer Drug From Medarex April 30, 2003 By James Etheridge PARIS - Diatos SA and Medarex Inc. signed a licensing agreement giving Diatos exclusive European rights to develop and commercialize a potential new cancer treatment. (BioWorld International)Read More
